Oncolytic viruses. (2020)

• Record Type: Book
• Further Information: Note: Edited by Christine E. Engeland.
• Editors: Engeland, Christine E
• Contents: 1. Introduction to Oncolytic Virotherapy Christine E. Engeland and John C. Bell 2. Methods for Modification of Therapeutic Viruses Claudia AP Hill, Luca Bau, and Robert Carlisle 3. Tumor Targeting of Oncolytic Adenoviruses using Bispecific Adapter Proteins Julia Niemann and Florian Kühnel 4. Development of Entry-targeted Oncolytic Measles Viruses Michael D. Mühlebach and Roberto Cattaneo 5. Insert Stability and In Vivo Testing of MicroRNA-Detargeted Oncolytic Picornaviruses Autumn J Schulze 6. Ex vivo Virotherapy with Myxoma Virus to Treat Cancer Nancy Y. Villa, Lina S. Franco, and Grant McFadden 7. Immunomodulation in Oncolytic Measles Virotherapy Laura Dietz and Christine E. Engeland 8. A Functional Assay to Determine the Capacity of Oncolytic Viruses to Induce Immunogenic Tumor Cell Death Tiphaine Delaunay, Carole Achard, Marc Grégoire, Frédéric Tangy, Nicolas Boisgerault, and Jean-François Fonteneau 9. Design and Production of Newcastle Disease Virus for Intratumoral Immunomodulation Gayathri Vijayakumar and Dmitriy Zamarin 10. Analysis of Immunological Treatment Effects of Virotherapy in Tumor Tissue Krishna Das, Carles Urbiola, Bart Spiesschaert, Philipp Mueller, and Guido Wollmann 11. Immunohistochemistry for Tumor-infiltrating Immune Cells after Oncolytic Virotherapy Dipongkor Saha and Samuel D. Rabkin 12. Detection of Tumor Antigen-specific T-cell Responses after Oncolytic Vaccination Jonathan G. Pol, Byram W. Bridle, and Brian D. Lichty 13. Evaluation of Oncolytic Virus Induced Therapeutic Tumor Vaccination Effects in Murine Tumor Models Rūta Veinalde 14. Delivery of Oncolytic Reovirus by Cell Carriers Elizabeth J. Ilett 15. In Vivo Bioimaging for Monitoring Intratumoral Virus Activity Liesa-Marie Schreiber, Carles Urbiola, Patrik Erlmann, and Guido Wollmann 16. Oncolytic Immunotherapy for Bladder Cancer Using Coxsackie A21 virus: Using a Bladder Tumour Precision-cut Slice Model System to Assess Viral Efficacy Kate Relph, Nicola Annels, Chris Smith, Marcos Kostalas, and Hardev Pandha 17. Use of Liquid Patient Ascites Fluids as a Pre-clinical Model for Oncolytic Virus Activity Eleanor M. Scott, Sally Frost, Hena Khalique, Joshua D. Freedman, Len W. Seymour, and Janet Lei-Rossmann 18. Generating Primary Models of Human Cancer to Aid in the Development of Clinically-relevant Oncolytic Viruses Brian A. Keller, Marie-Ève Wedge, Abera Surendran, and Carolina S. Ilkow 19. Considerations for Clinical Translation of MG1 Maraba Virus Caroline J. Breitbach 20. Fluorescence in Situ Hybridization (FISH) Detection of Viral Nucleic Acids in Oncolytic H-1 Parvovirus-treated Human Brain Tumors Irina Kiprianova, Alexandra Just, Barbara Leuchs, Jean Rommelaere, and Assia L. Angelova 21. Mathematical Modeling of Oncolytic Virotherapy Johannes P.W. Heidbuechel, Daniel Abate-Daga, Christine E. Engeland, and Heiko Enderling.
• Publisher Details: New York, NY : Humana Press
• Publication Date: 2020
• Extent: 1 online resource (xi, 329 pages), illustrations (some color)
• Subjects: 616.99/4019; Cancer -- Treatment -- Laboratory manuals; Viruses -- Therapeutic use -- Laboratory manuals; Electronic books
• Languages: English
• ISBNs: 9781493997947; 1493997947
• Related ISBNs: 9781493997930
• Notes: Note: Online resource; title from PDF title page (SpringerLink, viewed September 19, 2019).
• Access Rights: Legal Deposit; Only available on premises controlled by the deposit library and to one user at any one time; The Legal Deposit Libraries (Non-Print Works) Regulations (UK).
• Access Usage: Restricted: Printing from this resource is governed by The Legal Deposit Libraries (Non-Print Works) Regulations (UK) and UK copyright law currently in force.